What question did this study set out to answer?

The aim is to outline updated strategies for managing dyslipidaemias to lower cardiovascular risk.

June 8, 2020Russian Journal of Cardiology307 citationsOpen Access

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

FMFrançois Mach CBColin Baigent ACAlberico L. Catapano

Key Result

The 2019 ESC/EAS guidelines provide comprehensive recommendations for lipid modification to reduce cardiovascular risk in patients with dyslipidaemias.

Key Points

The aim is to outline updated strategies for managing dyslipidaemias to lower cardiovascular risk.
Developed guidelines based on recent evidence
Incorporated lipid modification strategies
Focused on cholesterol and triglycerides management
Lipid modification significantly decreased levels of LDL cholesterol
Enhanced guidelines improved patient adherence to treatment
Demonstrated a reduction in cardiovascular events among treated individuals

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

Esc . . Esc.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Cite This Study

Mach et al. (Mon,) reported a other. The 2019 ESC/EAS guidelines provide comprehensive recommendations for lipid modification to reduce cardiovascular risk in patients with dyslipidaemias.

synapsesocial.com/papers/6a18d793b6950308983083f4 https://doi.org/https://doi.org/10.15829/1560-4071-2020-3826